Overview

Clinical Study to Explore the Efficacy of ACT-129968 in Patients With Partly Controlled Asthma

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy and safety of ACT-129968 in subjects with partly controlled asthma on reliever therapy only.
Phase:
Phase 2
Details
Lead Sponsor:
Actelion
Idorsia Pharmaceuticals Ltd.
Treatments:
Albuterol